Biosimilars: Key Considerations
By IHOC
As biosimilars re-shape the treatment landscape, they’re creating new opportunities for health system pharmacy leaders to expand their influence. Pharmacy teams that understand the key components of biosimilars and the requirements for their approval can guide their health system on evaluating them for formulary inclusion.
Download this white paper to learn more about the key components of biosimilars and the specific questions pharmacy teams must ask in order to facilitate a successful partnership with their pharmacy and therapeutics committee. Also available is an actionable comparison tool that will help pharmacy teams discuss similarities between reference products and associated biosimilars with physician stakeholders.
Topics:
Biosimilars
